This company has been marked as potentially delisted and may not be actively trading. Accelerant (ARX) Competitors Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsCompetitorsHeadlinesInsider TradesShort InterestTrendsBuy This Stock ARX vs. DLB, LFUS, VSH, ROG, APH, and GLWShould you be buying Accelerant stock or one of its competitors? The main competitors of Accelerant include Dolby Laboratories (DLB), Littelfuse (LFUS), Vishay Intertechnology (VSH), Rogers (ROG), Amphenol (APH), and Corning (GLW). These companies are all part of the "electronic components" industry. Accelerant vs. Its Competitors Dolby Laboratories Littelfuse Vishay Intertechnology Rogers Amphenol Corning Dolby Laboratories (NYSE:DLB) and Accelerant (NYSE:ARX) are both mid-cap electronic components companies, but which is the superior business? We will compare the two businesses based on the strength of their analyst recommendations, institutional ownership, dividends, earnings, profitability, media sentiment, valuation and risk. Do analysts prefer DLB or ARX? Dolby Laboratories presently has a consensus target price of $95.75, indicating a potential upside of 33.95%. Accelerant has a consensus target price of $29.56, indicating a potential upside of 71.78%. Given Accelerant's higher probable upside, analysts plainly believe Accelerant is more favorable than Dolby Laboratories.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Dolby Laboratories 0 Sell rating(s) 2 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 2.60Accelerant 0 Sell rating(s) 7 Hold rating(s) 6 Buy rating(s) 1 Strong Buy rating(s) 2.57 Which has stronger valuation & earnings, DLB or ARX? Dolby Laboratories has higher revenue and earnings than Accelerant. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioDolby Laboratories$1.27B5.38$261.83M$2.7326.18Accelerant$602.60M6.28N/AN/AN/A Do insiders & institutionals have more ownership in DLB or ARX? 58.6% of Dolby Laboratories shares are held by institutional investors. 38.4% of Dolby Laboratories shares are held by insiders. Comparatively, 6.2% of Accelerant shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term. Does the media favor DLB or ARX? In the previous week, Dolby Laboratories had 13 more articles in the media than Accelerant. MarketBeat recorded 16 mentions for Dolby Laboratories and 3 mentions for Accelerant. Dolby Laboratories' average media sentiment score of 1.04 beat Accelerant's score of 0.00 indicating that Dolby Laboratories is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Dolby Laboratories 9 Very Positive mention(s) 1 Positive mention(s) 4 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Accelerant 0 Very Positive mention(s) 2 Positive mention(s) 0 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Neutral Is DLB or ARX more profitable? Dolby Laboratories has a net margin of 19.62% compared to Accelerant's net margin of 0.00%. Dolby Laboratories' return on equity of 11.52% beat Accelerant's return on equity.Company Net Margins Return on Equity Return on Assets Dolby Laboratories19.62% 11.52% 9.26% Accelerant N/A N/A N/A SummaryDolby Laboratories beats Accelerant on 9 of the 13 factors compared between the two stocks. Get Accelerant News Delivered to You Automatically Sign up to receive the latest news and ratings for ARX and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding ARX and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart ARX vs. The Competition Export to ExcelMetricAccelerant Industry SectorNYSE ExchangeMarket Cap$3.79B$2.39B$2.39B$21.64BDividend YieldN/A13.81%13.79%3.49%P/E RatioN/A25.6725.4029.75Price / Sales6.2811,816.1812,840.8968.31Price / CashN/A20.0060.0125.00Price / BookN/A3.653.164.58Net IncomeN/A-$411.68M-$445.27M$1.00B Accelerant Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)ARXAccelerant3.6151 of 5 stars$17.21-8.0%$29.56+71.8%N/A$3.79B$602.60M0.00N/AAnalyst ForecastDLBDolby Laboratories4.9424 of 5 stars$72.80+0.6%$103.00+41.5%+2.5%$6.98B$1.27B26.672,080Positive NewsAnalyst ForecastShort Interest ↑LFUSLittelfuse4.5954 of 5 stars$259.58+2.0%$234.50-9.7%+8.0%$6.43B$2.19B54.0816,000Positive NewsVSHVishay Intertechnology3.5793 of 5 stars$15.27+2.0%$19.00+24.4%-15.2%$2.07B$2.93B-23.5022,700Positive NewsAnalyst UpgradeROGRogers2.7526 of 5 stars$79.85+3.8%$85.00+6.5%-19.8%$1.45B$795.80M-22.623,200Trending NewsShort Interest ↑APHAmphenol4.3471 of 5 stars$112.59+1.7%$105.62-6.2%+87.1%$137.46B$15.22B44.86125,000News CoveragePositive NewsAnalyst RevisionGLWCorning4.0003 of 5 stars$69.68+0.5%$66.75-4.2%+84.0%$59.69B$13.12B74.1356,300Trending NewsAnalyst Downgrade Related Companies and Tools Related Companies DLB Competitors LFUS Competitors VSH Competitors ROG Competitors APH Competitors GLW Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NYSE:ARX) was last updated on 9/13/2025 by MarketBeat.com Staff From Our PartnersWhy Trump’s “Smart Dollar” could rewrite the rulesMUST SEE: Donald Trump's Radical Overhaul of the U.S. Dollar Congress just approved President Trump's lates...Stansberry Research | SponsoredTrump's Law S.1582: $21T Dollar Revolution ComingDo you have money in any of these banks? Chase. Bank of America. Citigroup. Wells Fargo. U.S. Bancorp. I...Brownstone Research | SponsoredRetire Comfortably with These New Monthly Income ETFs?Too many retirees lie awake at night, worried their savings won’t last. Traditional advice and tiny returns ju...Investors Alley | Sponsored“Fed Proof” Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredOctober 16 Changes the Microchip Game — and InvestingWhile everyone's chasing the same AI plays, George Gilder is focused on something completely different. He ...Banyan Hill Publishing | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredForget Tesla — This Tiny AI Stock Is Musk’s Real PlayWhile Wall Street focused on Tesla’s earnings, Elon Musk was quietly building a supercomputer so powerful it c...Behind the Markets | SponsoredNvidia Times 1,000,000Nvidia’s latest AI chip is a $25,000 powerhouse — with 80 billion transistors and the ability to perform 60 tr...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Accelerant Holdings Please log in to your account or sign up in order to add this asset to your watchlist. Share Accelerant With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.